Summary
1.
A simplified technique for the measurement of bile-acid pool size and synthesis rate has been developed in patients with liver disease. Isotope dilution studies in blood and bile were performed alter intravenous injection of [24-'*C]cholic acid with radioimmunoassay for the measurement of the bile-acid concentration. The interpolated pool sizes and synthesis rates, determined from results from both blood and bile, were not significantly different. The concentration of bile acids in the blood of healthy controls was not sufficiently elevated to permit application of this technique.
2. Three out of six patients with cirrhosis had a markedly reduced pool size compared with that of controls, whereas those with cholestasis had an unchanged pool size. The daily synthesis rate was reduced in both groups. Liver disease caused a redistribution (0-5-16%) of the bile-acid pool to the blood, which was associated with enhanced urinary excretion of cholic acid and its metabolites. Key words: bile acid, liver disease, pool size and turnover, renal excretion, serum specific radioactivity.
Introduct3on
Determination of bile-acid pool size and synthesis rate from specific radioactivity decay in duodenal Correspondence: Dr L. (Lindstedt, 1957; Hofmann & Hoffman, 1974) . However, application of the technique is limited by the technology required to determine individual bile-acid concentrations and by the relative inaccessibility of duodenal bile. The development of a sensitive radioimmunoassay has simplified the measurement of the primary conjugated bile acids (Spenney, Johnson, Hirschowitz, Mihas & Gibson, 1977) at low concentrations.
It has been suggested (Vlahcevic, Juttijudata, Bell & Swell, 1972) that the pool-size measurement, from the specific radioactivity decay of a radiolabelled bile acid by the technique of Lindstedt (1957) , could underestimate the total bile-acid pool if a disequilibrium existed between the enterohepatic and peripheral compartments. There is limited information about the degree of mixing between the peripheral and enterohepatic bile-acid compartments, and patients with liver disease who have increased bile-acid concentrations in their serum (Sherlock & Walshe, 1948; Makino, Nakagawa & Mashimo, 1969; Kaplowitz, Kok & Javitt, 1973; Korman, Hofmann & Summerskill, 1974; Barnes, Gallo, Trash & Moms, 1975; Demers & Hepner, 1976) differ from normal subjects, in that a significant portion of their bile-acid pool may be in the peripheral compartment. With [*'C1chenodeoxycholic acid Williams, Kaye, Baker, Hurwitz & Senior (1972) found a fivefold difference in specific radioactivity regression intercepts between plasma and jejunal bile, in a child with cholestatic cirrhosis, indicating a disequilibrium in the chenodeoxycholic acid pool.
The present studies were designed to determine: 
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(a) mixing between enterohepatic and peripheral bile acid compartments by following specific radioactivities of radiolabelled bile acid in each compartment in normal controls and in patients with liver disease; (b) the relative distribution of the bile-acid pool between serum and the enterohepatic compartments; (c) the urinary excretion of isotopically labelled cholic acid metabolites.
Methods

Patients
Sixteen subjects who gave written informed consent were studied according to a protocol approved by the Institutional Review Board of the University Hospital Medical Centre. The clinical and laboratory data for each patient are shown in Table 1 . Five normal subjects, who had no clinical or laboratory evidence of hepatocellular or biliarytract disease, received 50 pCi of [24-14Clcholic acid; six patients who had a clinical diagnosis of wellestablished cirrhosis, and five who had advanced cholestatic liver disease (three with primary biliary cirrhosis, two with sclerosing cholangitis) received 12-36 jKi of [24-14C]cholic acid. Both normal controls and patients were studied in the clinical research unit for a 96 h period after injection of the labelled compound. The [24-"Clcholic acid was injected into an antecubital vein and serial blood samples from both arms were obtained from all 11 patients and the controls at 8 h intervals; within each 24 h period one sample was taken in the fasting state and one 2 h after each of two standardized meals (4184 kJ each). In the five control subjects and six of the patients, duodenal samples were removed every 24 h after injection of the labelled compound with a nasogastric tube positioned fluoroscopicdy in the descending portion of the duodenum. Contraction of the gall bladder was stimulated by an intraduodenal injection of magnesium sulphate solution (2 ml, 500 gh). A portion (3-5 ml) of mixed duodenal bile was taken for analysis, and the the remainder returned via the intraduodenal tube. In addition samples of blood and bile were taken from a patient, via a biliary T-tube (in place for 2 years) every 8 h on two separate occasions 5 months apart. Total urine collections were made and portions were taken every 8 h throughout each study, from controls and the 11 patients, for 14C determinations.
Procedures with I4C
[24-14C1Cholic acid (specific radioactivity 109 pCi/mg; sterile, pyrogen-free; New England Nuclear, Boston, Massachusetts, U.S.A) used for injection was more than 98% pure as shown by thin-layer chromatography on silica-gel G with dichloroethane/acetic acid/water (10 : 10: 1.5, by vol.) as solvent. Distribution of bile-acid 14C radioactivity from bile was determined by thinlayer chromatography on silica-gel G plates (20 cm x 20 cm) (solvent system: hexane/ethyl acetate/ acetic acid/propan-2-01, 2 : 1 : 1 : 0.2, by vol.) after extraction with the non-ionic resin XAD-7 (Barnes & Chitranukroh, 1977) and hydrolysis with cholylglycine hydrolase (Sigma Chemical Co., St Louis, Missouri, U.S.A.) (Nair, Gordon, Gordon, Reback & Mendeloff, 1965) . Bile acids were located in adjoining standard lanes by using a 15% ethanolic phosphomolybdic acid spray. 14C in samples of serum, filtered duodenal bile and urine was determined with a 10 rnl Beckman Ready-solv H.P.
(Fullerton, California) and a Packard Tri-Carb scintillation spectrometer. The 14C radioactivity in each sample was corrected for quenching by using external standardization. Results were expressed as a percentage of the injected dose/unit volume of body fluid.
Bile-acid concentration
Bile-acid concentrations in serum and dilute filtered duodenal bile were determined by radioimmunoassay using the gamma-emitting bile acid, 1251-labelled cholylglycylhistamine (Spenney et al., 1977) . The antibody had the following crossreactivity at the concentrations used in this study: taurocholic acid, 100%; glycocholic acid, 36%; cholic acid, 10%; taurochenodeoxycholic acid, 1%; glycochenodeoxycholic acid, 36%.
No cross-reactivity was found for other endogenous bile acids or non-bile-acid steroids. Immunoreactive bile-acid concentrations were measured against response-curves generated by taurocholic acid. The values obtained correlated (r = 0.81, P < 0.001, n = 149) with total serum bile-acid concentration, measured by 3a-hydroxysteroid dehydrogenase after extraction with XAD-7 resin (Barnes & Chitranukroh, 1977) . The slope of the regression line was 1.15 5 0.06 (mean a SE, P < 0-Oool) and the intercept was -3.8 f 7.8 (P= The plasma volume of each subject studied was estimated from a nomogram of surface area based on height and weight (Diem & Lentner, 1970) . The nomogram estimations approximated to the 12'1-labelled serum albumin space determined in selected subjects. (sclerosing cholangitis), who had a T-tube positioned in the common bile duct; the broken line represents the linear regression fit to the combined (serum + bile) data.
Analysis of results
To test the hypothesis that measurements of specific radioactivity in serum are equivalent to those in bile, it was assumed that the tracer-dose of [24-''C]cholic acid was mixed with the total bile acid pool and distributed uniformly throughout the serum and bile compartments before significant irreversible loss. On the additional assumptions that the patient was in a steady-state condition, and the bile-acid pool behaved as a single compartment according to the model of Linstedt (1957) , the decay of specific radioactivity in either the serum or bile compartment should follow first-order kinetics.
Bile-acid specific radioactivity was logarithmically transformed and, its decay with time ( Fig.  1) was analysed by least-squares linear regression to determine an intercept and slope (fractional turnover-rate) for calculating bile-acid pool size and synthesis rate. The regression lines obtained from serum and bile were compared by analysis of the differences in regression slopes and intercepts, assuming homogeneity of residual variances and paired t-tests, and between the groups by Duncan's multiple range test (Snedecor & Cochran, 1967) .
The slow rate of decay in specific radioactivity in patients with liver diseases affects the value of the correlation coefficient (r). With a slow rate of decay of specific radioactivity r tends towards zero, even though the error about the regression line is unchanged. Estimates of the initial specific radioactivity are therefore as accurate as those with a rapidly decaying specific radioactivity. The accuracy of estimates of the slope is dependent on its magnitude (Barrett, 1974) .
Urinary excretion
The cumulated urinary isotope excretion curves were fitted by non-linear regression analysis to eqn.
(1):
In eqn.
(1) X = cumulated urinary excretion, A = fraction of excreted dose appearing in the urine, t = time, s = a constant related to the decay in specific radioactivity in the blood and b = a constant required to obtain a close fit over the region 0-24 h. It may represent the effect of lack of equilibration between the serum and biliary compartments. As t tends towards infinity, A = X (infinity).
A is the fraction of the total dose excreted in the urine. The fraction of the dose eliminated over the 96 h period (as judged from the rate of decay of specific radioactivity) which appeared in the urine over the same period was used as an initial estimate of A.
Results
Bile-serum correlation
Similarity of bile-acid specific radioactivity decay curves was established by using linear regression analysis after logarithmic transformation of the results (Table 2 ). Patient no. 11, with a common bile-duct T-tube in place for 2 years, was studied on two occasions 5 months apart; in each study both bile and serum were sampled every 8 h ( Fig. 1 b and Table 2 ). In six other patients samples (3-5 ml) of bile were taken at 24 h intervals and serum samples taken every 8 h. Among patients with liver disease no significant differences (P > 0-5) were found for slopes and intercepts of regression lines between their individual serum and bile decay curves (Table  2 ). That finding alone shows the statistical similarity between peripheral and enterohepatic bile-acid specific radioactivities.
Calculation of pool size (pmol/kg) and synthesis rate (pmol day-' kg-') from the patient's serum and bile decay curves (Table 3 ) enabled a paired comparison of the two compartments in seven of the 11 patients. For any one individual, bile-acid pool size and synthesis rate (based on the turnover TABU 2. Leasf-squares linear regression jmrameters derived from decay curves of I'C spec@ radioacfiviry Probability values show significance of difierenccs in regression slopes and intercepts between bile and serum specific radioactivity regressions, assuming homogeneity of residual variances (P < 0.05 needed for significant difference).
There was no significant difference between regressions in normal individuals (P = 0.39 intercepts, P = 0.23 slopcs, one-way analysis of variance). Intercept = natural logarithm of the specific radioactivity. Slope = 10-' x natural logarithm of the specific radioactivityh. and synthesis rates (0.9-17.7 pmol day-' kg-l) among these seven patients was large enough for comparison of pool size and synthesis rate with linear regression analysis to be made. The intercepts of the pool-size and turnover-rate regression lines were not significantly different from the origins (P > 0.5 and P > 0.5 respectively); the regression slopes were not significantly different from the theoretical slopes of one (P > 0.4 and P > 0.5 respectively).
Although a maximal dose (50 pCi) of bile-acid tracer was given in normal controls, the amount of 14C remaining in their blood was too low to determine accurately specific radioactivity regressions. Analysis of the duodenal bile specific radioactivity regressions in normal controls demonstrated significant correlation with respect to time (r = 0.92, P < 0.05) ( Table 2 ). Normal pool size and synthesis rates were 51.7 f 7.4 pmol/kg (mean? SE) and 16-0f 3.2 pmol day-' kg-' respectively ( Table 4) . The bile-acid pool size was reduced, although not significantly, in patients with cirrhosis (33.9 6.0 pmol/kg); it was unchanged in those with cholestasis (56.2 f 9-9 pmoykg). Bile-acid synthesis rate was significantly reduced among both patient groups (P < 0.05, Duncan's multiple range test). The conversion of [14Clcholic acid into [14Cldeoxycholate as determined by thin-layer chromatography did not exceed 4% in the bile from patients with liver disease. However, in bile from normal controls, [14Cldeoxycholate radioactivity was 34% of the total radioactivity after 4 days. It should be emphasized that the values obtained for bile-acid pool size are estimates of total bile-acid pool size and not that of cholic acid alone. The synthesis rate (as defined in this study) is a complex term which represents the product of the total bile-acid pool and the turnover of cholic acid.
Bile-acid pool distribution and renal excretion
Less than 0.1% of the bile-acid pool was in the peripheral compartment of normal subjects (concentration 0.1-0-9 ,umol/l aRer an 18 h fast) compared *th 0-5-16.2% in patients with liver disease (concentration 10-167 pmol/l) ( Table 4) .
Renal excretion of 14C radioactivity was nonlinear with time (Fig. 2) ; this was most likely due to the declining specific radioactivity rather than a timedependent change in renal bile-acid clearance. The curves of accumulated renal isotope excretion were fitted to eqn. (1) in order to determine the percentage (A) of total [14Clcholic acid turnover undergoing renal excretion. An initial estimate of Hat. P > 0.4).
the percentage renal excretion was determined from the ratio of the 96 h renal excretion to total "C excretion during this period (Table 4) , calculated from the specific radioactivity decay curves. Values of A from the computer-fitted functions were correlated with the initial estimates (r = 0.83, n = 12, P < 0.05), suggesting that the estimates were useful in predicting the fraction of the dose excreted in the urine. The percentage of the dose excreted by the renal route was positively correlated (P < 0.05) with serum bile-acid concentration ( Table 4) . Normal subjects excreted via the urine only 0.5-2.2% of the total 14C excreted (70%) in the 96 h period. However, in patients with liver disease 14C-labelled bile-acid turnover, as determined from the slow rate of decay of specific radioactivity, was decreased, and renal excretion was more than in controls ( Table 4) . In one patient (no. 8) renal excretion accounted for more than half the total turnover of [l4C1cholic acid. Patients with cholestatic liver disease excreted a significantly greater portion of 14C radioactivity by the renal route than did patients with cirrhosis, 30.9 k 7.0 and 17.7 f 5.3% respectively (P < 0.05).
Discussion
These studies have shown that, in patients with liver disease, bile-acid kinetics (pool size and synthesis rate) may be determined in either the peripheral blood compartment or the biliary compartment, the site where such measurements have been previously made (Lindstedt, 1957; Hofmann & Hoffman, 1974) . This results from the mixing of the peripheral blood and enterohepatic compartments, as evidenced by the similar specific radioactivity decay curves in each.
The frequency at which blood samples were taken (8 h) resulted in less biased estimates of pool size and synthesis rate, than those obtained with only fasting samples, since both may vary throughout the day (Hoffman & Hofmann, 1977) . Indeed, fluctuations in patient-serum specific radioactivity observed between samples ( Fig. 1) were taken to represent daily variation related to several factors: increased urinary bile-acid excretion, mealstimulated gall bladder contraction, increased reflux of newly synthesized bile acid into the serum of cholestatic patients and variable hepatic synthesis. The greater variance introduced by sampling at different times throughout enterohepatic cycles is offset by the convenience and sensitivity of the radioimmunoassay technique (Spenney et al., 1977) . This variation and the low rate of decay in specific activity combined to give correlation coefficients lower than those observed in control subjects. Even so, from statistical considerations (Barrett, 1974) the intercept and hence pool size would still be accurately measured. In order to determine accurately fractional turnover, the specific radioactivity decay should be followed for a longer period of time.
Since the radioimmunoassay method used in this study correlated with the total bile-acid enzymatic assay, our results approximate total bile-acid specific radioactivity and hence total bile-acid pool size rather the pool size of cholic acid alone. The unequal cross-reactivities of the bile acids in the radioimmunoassay may have caused some error in individual patients. Comparison of these results with those derived from standard chromatographic techniques should be viewed with caution. The use of monospecific antibodies, or combination of techniques used in this study with preliminary chromatographic separation, could resolve suspected discrepancies. This would take into account alteration in bile-acid composition, namely glycine/taurine and cholic acidlchenodeoxycholic acid ratios (Carey, 1958) . The composition of bile acid that we found in serum and bile of patients with cirrhosis agrees with that reported by Struthers, Mehta, Kaye & Naylor (1977) . The samplcs of bile were diluted to be approximately the same concentration as serum samples in order to overcome the changing antibody cross-reactivity with increasing concentration. Little or no radioactivity was found other than in cholic acid and its conjugates in the patients with liver disease.
However, in control subjects substantial amounts (34% of total acid turnover) appeared at the end of the study period as deoxycholic acid conjugates, which were not detected by the radioimmunoassay procedure. This result would suggest that the normal duodenal bile specific radioactivity regressions were slightly overestimating the intercept and hence underestimating the pool size. This may explain the failure to find a difference between the pool size in the normal subjects and that in subjects with cirrhosis as reported by Vlahcevic et al. (1972) .
It is likely that similar specific radioactivity in the serum and bile compartments is the result of rapid fractional exchange between these compartments compared with faecal and urinary excretion. It should be noted that the rapid compartmental equilibration which occurs with cholic acid would not apply to those molecules having enhanced excretion (e.g. bile acid sulphates). Since sulphation could result in significant excretion before complete compartmental equilibration, a double rather than single exponential decay would be expected; this has also been reported for lithocholic acid kinetics (Allan, Thistle 8c Hofmann, 1976) .
The results obtained also reflect an enhanced total renal excretion of cholic acid and its metabolites for patients with impaired portobiliary bile-acid transport. It has not been possible before to calculate the importance of urinary excretion of cholic acid metabolites, although for chenodeoxycholic acid urinary excretion of its sulphated metabolites in patients with cirrhosis accounted for 25% of total chenodeoxycholic acid turnover (Stiehl, Ast, Czygan, Frohling, Raedsch 8c Kommerell, 1978) . In this study the mean percentage urinary excretion of cholic acid metabolites was 17.7% in patients with cirrhosis and 30.9% in those with advanced cholestasis. The differences between cirrhosis and advanced cirrhosis can be accounted for by the increased serum conjugated cholic acid pool rather than involving a specific renal mechanism (Barnes, Gollan & Billing, 1977) .
Quantitative information on disorders of bileacid metabolism in liver disease may be rapidly and simply obtained, from radioisotopic bile-acid dilution and distribution in peripheral blood and urine, with a minimum amount of discomfort and inconvenience to the experimental subject.
